Therapeutic Advances in Hematology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.8 | Q2 | 60.2% | 1.018 | Q1 | 84.3% |
| 2024 | 3.1 | Q2 | 69.7% | 1.180 | Q1 | 88.1% |
| 2023 | 3.4 | Q2 | 83.0% | 1.258 | Q1 | 90.1% |
| 2022 | 3.4 | Q2 | 74.5% | 1.011 | Q2 | 86.5% |
| 2021 | 5.4 | Q2 | 80.4% | 0.437 | Q3 | 63.0% |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | 0.702 | Q2 | 77.0% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2040-6215
ISSN
2040-6207
region
Western Europe
coverage
2010-2026